Studies on the pharmacokinetics and bioequivalence of domestic gatifloxacin capsules in healthy volunteers
Ai Shi
Abstract
Ai Shi
Abstract
OBJECTIVE To observe the bioavailability of domestic gatifloxacin capsules and imported tablets.METHOD A single oral dose of 400 mg domestic capsules or imported tablets were given to 20 healthy volunteers in a randomized crossover study. The concentrations of gatifloxacin were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as following: AUC 0~36 (31.60±5.45) and (30.37±5.74) μg·h·mL -1 , c max (3.32±0.55) and (3.37±0.50) μg·mL -1 , t max (1.65±0.37) and (1.55±0.46) h,respectively.The relative bioavailability of domestic capsules to imported tablets was (104.6± 8.6 )%.CONCLUSION There were no significant difference between the parameters of the two preparations( P 0.05).The results demonstrated that the two preparations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To observe the bioavailability of domestic gatifloxacin capsules and imported tablets.METHOD A single oral dose of 400 mg domestic capsules or imported tablets were given to 20 healthy volunteers in a randomized crossover study. The concentrations of gatifloxacin were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as following: AUC 0~36 (31.60±5.45) and (30.37±5.74) μg·h·mL -1 , c max (3.32±0.55) and (3.37±0.50) μg·mL -1 , t max (1.65±0.37) and (1.55±0.46) h,respectively.The relative bioavailability of domestic capsules to imported tablets was (104.6± 8.6 )%.CONCLUSION There were no significant difference between the parameters of the two preparations( P 0.05).The results demonstrated that the two preparations were bioequivalent.
Key concepts: Bioequivalence, Bioavailability, Gatifloxacin, Pharmacokinetics, Crossover study, Pharmacology, Significant difference, Medicine